NCT07102082 Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
| NCT ID | NCT07102082 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Roswell Park Cancer Institute |
| Condition | Smoking Behaviors |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2025-09-25 |
| Primary Completion | 2027-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2025-09-25 with a primary completion date of 2027-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.
Eligibility Criteria
Inclusion Criteria: * Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming). * Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year. * Open to trying a non-combusted oral tobacco product. * Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study. * Have the ability to read, write, and communicate in English. * Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure Exclusion Criteria: * Plan to quit smoking in the next 30 days. * Use of smokeless tobacco at least weekly in the last 6 months. * Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus. * Unwilling or unable to follow protocol requirements. * Pregnant or planning to become pregnant (by self report)
Contact & Investigator
Richard O'Connor
PRINCIPAL INVESTIGATOR
Roswell Park
Frequently Asked Questions
Who can join the NCT07102082 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Smoking Behaviors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07102082 currently recruiting?
Yes, NCT07102082 is actively recruiting participants. Contact the research team at askroswell@roswellpark.org for enrollment information.
Where is the NCT07102082 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT07102082 clinical trial?
NCT07102082 is sponsored by Roswell Park Cancer Institute. The principal investigator is Richard O'Connor at Roswell Park. The trial plans to enroll 160 participants.